Paying users zone. Data is covered by .

  • Get to Abbott Laboratories for $17.99, or

  • get to whole website for at least 3 months from $49.99.

$17.99

Income Statement Quarterly Data

Difficulty: Beginner

Abbott Laboratories, Consolidated Income Statement (quarterly data)

USD $ in millions

 
3 months ended Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013
Net sales
Cost of products sold, excluding amortization of intangible assets
Amortization of intangible assets
Gross profit
Research and development
Selling, general and administrative
Operating earnings (loss)
Interest expense
Interest income
Net foreign exchange gain (loss)
Net loss on extinguishment of debt
Other income (expense), net
Earnings (loss) from continuing operations before taxes
Tax expense on earnings (loss) from continuing operations
Earnings (loss) from continuing operations
Earnings (loss) from discontinued operations, net of tax
Gain (loss) on sale of discontinued operations, net of tax
Net earnings (loss) from discontinued operations, net of tax
Net earnings (loss)
Source: Abbott Laboratories, Quarterly and Annual Reports
Item Description The company
Net sales Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains. Abbott Laboratories's net sales increased from Q3 2017 to Q4 2017 but then slightly declined from Q4 2017 to Q1 2018.
Operating earnings (loss) The net result for the period of deducting operating expenses from operating revenues. Abbott Laboratories's operating earnings (loss) declined from Q3 2017 to Q4 2017 and from Q4 2017 to Q1 2018.
Earnings (loss) from continuing operations before taxes Sum of operating profit and nonoperating income (expense) before income (loss) from equity method investments, income taxes, extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest. Abbott Laboratories's earnings (loss) from continuing operations before taxes declined from Q3 2017 to Q4 2017 and from Q4 2017 to Q1 2018.
Earnings (loss) from continuing operations This represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses and taxes from ongoing operations before extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest. Abbott Laboratories's earnings (loss) from continuing operations declined from Q3 2017 to Q4 2017 but then increased from Q4 2017 to Q1 2018 not reaching Q3 2017 level.
Net earnings (loss) The portion of consolidated profit or loss for the period, net of income taxes, which is attributable to the parent. If the entity does not present consolidated financial statements, the amount of profit or loss for the period, net of income taxes. Abbott Laboratories's net earnings (loss) declined from Q3 2017 to Q4 2017 but then increased from Q4 2017 to Q1 2018 not reaching Q3 2017 level.

Top